AstraZeneca's Community of Excellence gathers alliance management stakeholders across the organization to share best practices, trends, and ideas—and it costs nothing! This “simple, lean, and efficient” approach to COEs was featured at the 2022 ASAP BioPharma Conference. Continue Reading
In discovery-phase alliances, alliance managers need to have their eyes on the big picture and broader company strategy when working with scientists who are often too narrowly focused on short-term objectives. Three Takeda executives explained in an 2022 ASAP BioPharma Conference presentation. Continue Reading
Caroline Rader, Chris Black, Ken Marran, and Ryan Lenox brought ASAP BioPharma Conference took attendees behind the curtain of Merck's Big-Pharma-to-Big-Pharma alliances, which are responsible for major multibillion-dollar, market-moving drug candidates. Continue Reading
Jim Mullen of Editas Medicine delivered tips on dealing with “the Bermuda Triangle of contract issues”—decision rights, dispute resolution, and termination—in his ASAP BioPharma Conference keynote. When conflict arises, get agreement on the facts, but don't require a consensus decision. Continue Reading
What do biopharma alliance managers need to know about digital transformation? Microsoft's Elena Bonfiglioli outlined three things in her ASAP BioPharma Conference keynote: 1) culture that promotes privacy, 2) competencies, and 3) trust. Continue Reading
How do you develop therapies that will help capture part of the rare/orphan disease market that is expected to exceed $300 billion in 2030? It takes an ecosystem of seven players, explained Jeff Livingstone in his ASAP BioPharma Conference presentation last last month. Continue Reading
Influence is what helps build bridges when partners are at odds. “It is perhaps the hardest part of the job, but it is the part of the job that delivers the greatest value." The Rhythm of Business delivered a master class on the subject at the 2022 ASAP BioPharma Conference. Continue Reading
According to our ASAP BioPharma Conference keynote speaker, the future for alliance managers is bright. In fact, their particular blend of skills and capabilities could just light their way up to the corner offices where the C-level executives live. Continue Reading
In a 2022 ASAP BioPharma Conference marked by record-breaking attendance, Alex Waldron, CEO of Wellinks, painted a picture of the very near future of digital health partnering that awaits all those working in the trenches of biopharma alliance management. If not now, then soon! Continue Reading
The answer to the conundrum of increasing complexity, diversity, and sheer numbers of biopharma partnerships? It just might be a strategy of complete and utter transparency with our partners, according to this year's speaker at the ASAP BioPharma Conference Leadership Forum. Continue Reading
Jim Mullen of Editas Medicine will tell ASAP BioPharma Conference attendees how to prevent intangible factors from derailing an alliance, including senior leadership turnover; asymmetries in knowledge, impact, size, or importance of the partner; or vague contract language, to name a few. Continue Reading
Novartis and Microsoft executives will demystify basic tech concepts, such as cloud-based solutions, tech stacks, and AI, as they explain what all biopharma alliance managers need to know about digital transformation—and why they need to understand it—at the ASAP BioPharma Conference Sept. 28–30. Continue Reading
